Skip to main content

Company News

March 13, 2024

Antimicrobial Resistance Makes It Harder to Treat Urinary Tract Infections and Increases Risk of Sepsis and AKI

Antimicrobial resistant bacteria pose a major public health threat because they limit treatment options for infectious diseases. Common ailments like urinary tract infections (UTIs), which have often been easily and quickly cured by antibiotics historically, are becoming harder to treat due to resistant bacteria. Not only does this prolong discomfort for those suffering from UTIs, it also presents the danger that the infection may lead to a more serious condition.
  • December 18, 2023

    CATTI and bioMérieux Canada are joining forces to support the development of a qualified workforce in advanced therapies

    CATTI, Canadian Advanced Therapies Training Institute, and bioMérieux Canada are combining their respective strengths to enhance the training of the workforce in advanced therapies and the production of quality control solutions (for the pharmaceutical industries).
  • December 13, 2023

    bioMérieux celebrates the First Graduating Class of its Academy of microbiology in Latin America

    In 2020, bioMérieux launched an innovative educational program in Latin America dedicated to healthcare professionals to strenghten their understanding and practice of microbiology.
  • November 28, 2023

    A Stronger Business Relationship to Enhance bioMérieux’s BIOFIRE® SPOTFIRE® Presence in the US Outpatient Diagnostic Market

    bioMérieux has strengthened its relationship with McKesson Medical-Surgical, a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere.
  • April 20, 2023

    bioMérieux and JMI Labs partner against antimicrobial resistance (AMR)

    bioMérieux and JMI Laboratories (JMI) are announcing a six-year partnership to undertake collaborative projects evaluating the performance and increasing potential of rapid and innovative microbiology diagnostics as important tools in the battle against AMR.

Follow us on Socials for more news!